Digoxin Polyclonal Antibody, RBITC Conjugated
Product Specifications
Background
Digoxin is a beta blocker drug originally derived from the foxglove plant, Digitalis lanata. Digoxin is used primarily to improve the pumping ability of the heart in congestive heart failure (CHF), and treat problems such as high blood pressure. It is also used to help normalize some dysrhythmias (abnormal types of heartbeat) .
Synonyms
Digoxigenin; Lanoxin.
Host
Rabbit
Target
Digoxin
Clonality
Polyclonal
Isotype
IgG
Conjugation
RBITC
Source
BSA conjugated to Dig
Applications
IF (IHC-P)
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Cross Reactivity Details
Digoxin
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15087270 1 Vial
Lentiviral human AWAT1 shRNA (UAS) - Lentiviral human AWAT1 shRNA (UAS) (100)
Ask
View Details 
GTR15212532 1 Vial
Lentiviral mouse Tpr shRNA (UAS) - Lentiviral mouse Tpr shRNA (UAS, RFP) (100)
Ask
View Details